Publications by authors named "N A Avdonkina"

The investigation of in-vitro response of cell cultures derived from tumor material of individual patients with similar tumor localizations to photodynamic treatment is presented. Tumor types included in the research were renal cell carcinoma, melanoma and alveolar, synovial, lypo- and osteo- sarcomas. Long-term observations of treatment-induced morphological changes in cells were performed by means of digital holographic microscopy.

View Article and Find Full Text PDF

Tumorigenesis is related to the generation of heterogeneous tumor cell population, which is the result of genetic and epigenetic alterations followed by clonal selections and subsequent expansion. In basic studies genetic, histological and morphological diversity of different clones within a patient's neoplasm and specifics of their interrelation with patient's immune system are investigated mostly on the models of tumors of epithelial origin. Mesenchymal tumors such as soft tissue and bone-derived sarcomas (STBS) have been poorly studied in this regard.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores how tumor clones in metastatic soft tissue and bone sarcomas evolve, highlighting the challenges posed by intratumor heterogeneity in cancer treatment development.
  • Researchers cultured tumor samples from 54 patients, successfully cloning 83 clones from 22 cases, and linked high clonogenic potential (CP) with increased cell growth and specific gene expressions.
  • The findings show that while some cancer-testis genes were activated, chemotherapy-resistant clones likely existed before treatment, suggesting that patients with high CP had poorer overall survival rates compared to those with low CP.
View Article and Find Full Text PDF

Background: Autologous dendritic cells (DC) loaded with tumor-associated antigens (TAAs) are a promising approach for anticancer immunotherapy. Polyantigen lysates appear to be an excellent source of TAAs for loading onto the patient's dendritic cells. Cancer/testis antigens (CTA) are expressed by a wide range of tumors, but are minimally expressed on normal tissues, and could serve as a universal target for immunotherapy.

View Article and Find Full Text PDF